Stayble Therapeutics AB (publ) (STO:STABL)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3000
-0.0040 (-1.32%)
Sep 15, 2025, 4:24 PM CET

Stayble Therapeutics AB Company Description

Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration.

The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.

Stayble Therapeutics AB (publ)
CountrySweden
Founded2015
IndustryBiotechnology
SectorHealthcare
Employees2
CEOAndreas Gerward

Contact Details

Address:
Lennart Torstenssonsgatan 6
Gothenburg, 412 56
Sweden
Websitestaybletherapeutics.se

Stock Details

Ticker SymbolSTABL
ExchangeNasdaq Stockholm
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencySEK
ISIN NumberSE0013513652
SIC Code2834

Key Executives

NamePosition
Andreas Gerward M.Sc.Co-Founder and Chief Executive Officer
Mattias Munnich M.Sc.Co-Founder
Erik KullgrenChief Financial Officer
Anders Lehmann Ph.D.Chief Scientific Officer